Gastro esophageal reflux disease is associated with absence from work: Results from a prospective cohort study

World Journal of Gastroenterology

Volumn 11, Issue 45, 2005, Pages 7148-7151

  Leodolter, Andreas ^a   Nocon, Marc ^b   Kulig, Michael ^b   Willich, Stefan N ^b   Malfertheiner, Peter ^a   Labenz, Joachim ^c  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c Ev Jung Stilling Krankenhaus   (Germany)

Author keywords

Gastro esophageal reflux; Medical economics; Sick leave

Indexed keywords

ESOMEPRAZOLE; PROTON PUMP INHIBITOR;

ABSENTEEISM; ARTICLE; CALCULATION; COHORT ANALYSIS; CORRELATION ANALYSIS; COST OF ILLNESS; ECONOMICS; EMPLOYEE; EMPLOYMENT; EUROPE; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GERMANY; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PREVALENCE; PRODUCTIVITY; SALARY; STATISTICS; WORK DISABILITY;

EID: 31544445517     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i45.7148     Document Type: Article

References (16)

1. Armstrong, D and Jones, R. Gastroesophageal reflux disease (GERD) symptoms (GS) in 5 European countries: a common and poorly understood condition. Gastroenterology 2001; 120: 2180 [A]
2. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-1456
3. Valle C, Broglia F, Pistorio A, Tinelli C, Perego M. Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig Dis Sci 1999; 44: 1848-1852
4. Wahlqvist P. Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life. Am J Gastroenterol 2001; 96: S57-S61
5. Frank L, Kleinman L, Ganoczy D, McQuaid K, Sloan S, Eggleston A, Tougas G, Farup C. Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilization and quality of life. Dig Dis Sci 2000; 45: 809-818
6. Henke C J, Levin T R, Henning J M, Potter L P. Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol 2000; 95: 788-792
7. Sandler R S, Everhart J E, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122: 1500-1511
8. Kulig M, Nocon M, Vieth M, Leodolter A, Jaspersen D, Labenz J, Meyer-Sabellek W, Stolte M, Lind T, Malfertheiner P, Willich S N. Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol 2004; 57: 580-589
9. An evidence-based appraisal of reflux disease management-the Genval Workshop Report. Gut 1999; 44 Suppl 2: S1-16
10. Koopmanschap MA, Rutten F F. A practical guide for calculating indirect costs of disease. Pharmacoeconomics 1996; 10: 460-466
11. Schwabe U, Paffrath D. Arzneiverordnungs-Report 2003. Springer: Berlin, 2004
12. Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, Lind T, Meyer-Sabellek W, Malfertheiner P, Stolte M, Willich S N. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003; 18: 767-776
13. Farup C, Kleinman L, Sloan S, Ganoczy D, Chee E, Lee C, Revicki D. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med 2001; 161: 45-52
14. Agreus L, Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics 2002; 20: 347-355
15. Stewart W F, Ricci J A, Leotta C. Health-related lost productive time (LPT): recall interval and bias in LPT estimates. J Occup Environ Med 2004; 46: S12-S22
16. Dean B B, Crawley J A, Reeves J D, Aguilar D, Sullivan S, Berglund R, Dubois R. The costs of gastroesophageal reflux disease: It's what you don't see that counts. J Managed Care Medicine 2003; 7: 6-13